Clinical trial

Diagnosis Value of SEMA4C in Breast Cancer

NCT03662633

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2023-09-01

PhaseN/A

Study timeline

Study start (estimated)2023-09-01Date precision: day

Registry last updated2022-10-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Neoplasm Femaleunresolved

Interventions

Breast cancer groupDIAGNOSTIC_TEST

Benign breast tumor groupDIAGNOSTIC_TEST

Sponsors & collaborators

Tongji Hospitallead sponsor

Hubei Cancer Hospitalcollaborator

Qilu Hospital of Shandong Universitycollaborator

Wuhan Central Hospitalcollaborator

Xiangyang Central Hospitalcollaborator

The First People's Hospital of Jingzhoucollaborator

The First Affiliated Hospital with Nanjing Medical Universitycollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03662633 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.